By Deena Beasley April 2 (Reuters) - The sidelining by U.S. Health Secretary Robert F. Kennedy Jr. of the advisory panel that ...

With the campaign, Highlights REAL, they are spotlighting the everyday experiences of advanced prostate cancer patients and ...

Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing ...

By partnering with other like-minded organizations to fund targeted RFAs throughout the year, ACS is able to invest in new ...

A recent study published in The New England Journal of Medicine found that transdermal estradiol (tE2) therapy was ...

Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP ...

Lucida’s software is designed to identify prostate cancer ‘within minutes’ and overcome diagnosis delays associated with ...

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

New FDA approvals and emerging trial data drive two pivotal 2026 NCCN guideline updates: lutetium-177 PSMA-617 for ...

To better predict these risks, the new guidelines recommend that all stage 2 and 3 colorectal tumors undergo molecular ...

New figures published by Public Health Scotland show that just 65.5% of cancer patients in NHS Lothian started treatment ...